Cardiotoxicity of trastuzumab emtansine (T-DM1): a single-center experience
Objective New anti-cancer drugs promise to increased survival benefits and reduce adverse events. Trastuzumab emtansine (T-DM1) is a novel anti-human epidermal growth factor receptor 2 agent that has shown minimal cardiotoxicity in clinical trials. However, data on real-life outcomes are required. M...
Na minha lista:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2021-12-01
|
| coleção: | Journal of International Medical Research |
| Acesso em linha: | https://doi.org/10.1177/03000605211053755 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|